CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-16 | MOTT DAVID M Director | Purchase | +11,779 | $1.20 | $14K | 63,157 |
| 2022-02-15 | MOTT DAVID M Director | Purchase | +19,552 | $1.20 | $23K | 51,378 |
| 2022-02-14 | MOTT DAVID M Director | Purchase | +8,500 | $1.18 | $10K | 31,826 |
| 2022-02-11 | MOTT DAVID M Director | Purchase | +14,573 | $1.23 | $18K | 23,326 |
| 2022-02-10 | MOTT DAVID M Director | Purchase | +8,753 | $1.29 | $11K | 8,753 |
| 2022-01-28 | Attie Kenneth SVP, CMO | Grant or award | +34,100 | 34,100 | ||
| 2022-01-28 | Attie Kenneth SVP, CMO | Grant or award · Stock Option (right to buy) | +34,100 | 34,100 | ||
| 2022-01-28 | Ballal Rahul D. Chief Executive Officer | Grant or award | +131,400 | 137,009 | ||
| 2022-01-28 | Ballal Rahul D. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +131,400 | 131,400 | ||
| 2022-01-28 | GRAY MICHAEL CFO & COO | Grant or award | +39,350 | 42,312 | ||
| 2022-01-28 | GRAY MICHAEL CFO & COO | Grant or award · Stock Option (right to buy) | +39,350 | 39,350 | ||
| 2022-01-25 | New Enterprise Associates 14, L.P. 10% owner | Sale | −102,952 | $1.47 | $152K | 3,305,601 |
| 2022-01-24 | New Enterprise Associates 14, L.P. 10% owner | Sale | −19,984 | $1.55 | $31K | 3,408,553 |
| 2022-01-21 | New Enterprise Associates 14, L.P. 10% owner | Sale | −11,622 | $1.67 | $19K | 3,428,537 |
| 2022-01-20 | New Enterprise Associates 14, L.P. 10% owner | Sale | −6,295 | $1.81 | $11K | 3,440,159 |
| 2022-01-19 | New Enterprise Associates 14, L.P. 10% owner | Sale | −13,412 | $1.82 | $24K | 3,446,454 |
| 2022-01-18 | New Enterprise Associates 14, L.P. 10% owner | Sale | −6,848 | $1.89 | $13K | 3,459,866 |
| 2022-01-14 | New Enterprise Associates 14, L.P. 10% owner | Sale | −9,707 | $1.91 | $19K | 3,466,714 |
| 2022-01-13 | New Enterprise Associates 14, L.P. 10% owner | Sale | −7,209 | $1.93 | $14K | 3,476,421 |
| 2022-01-12 | New Enterprise Associates 14, L.P. 10% owner | Sale | −4,634 | $2.02 | $9K | 3,483,630 |
Page 35 of 37 · 724 trades